Correlation Between Terns Pharmaceuticals and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Pliant Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Pliant Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Pliant Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Terns and Pliant is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Pliant Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Pliant Therapeutics. In addition to that, Terns Pharmaceuticals is 1.08 times more volatile than Pliant Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.12 per unit of volatility. If you would invest 1,421 in Pliant Therapeutics on August 24, 2024 and sell it today you would lose (136.00) from holding Pliant Therapeutics or give up 9.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Pliant Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Pliant Therapeutics |
Terns Pharmaceuticals and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Pliant Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Terns Pharmaceuticals vs. Lyra Therapeutics | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. Cingulate Warrants | Terns Pharmaceuticals vs. SAB Biotherapeutics |
| Pliant Therapeutics vs. Lyra Therapeutics | Pliant Therapeutics vs. Hookipa Pharma | Pliant Therapeutics vs. Cingulate Warrants | Pliant Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |